ArticleOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery2026
Prediction and Prognostication of Peripheral Blood Biomarkers in Head and Neck Cutaneous Squamous Cell Carcinoma.
Article in Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWhile many with head and neck cutaneous squamous cell carcinomas (cHNSCC) respond well to surgery alone, there is a need to refine traditional staging systems. We aim to identify whether peripheral blood biomarkers (PBBMs) may enhance current staging for prognostication and adjuvant treatment selection. STUDY
designRetrospective cohort study.
settingSingle, tertiary academic referral center.
methodsPreoperative and postoperative PBBMs and patient/disease characteristics were collected for adults surgically treated for cHNSCC at an academic center from 2016 to 2022. Pearson correlations and t-tests were utilized to correlate PBBMs with tumor characteristics. Univariate and multivariate analysis was performed to correlate predictors with overall survival. Staging systems were compared using Kaplan-Meier regression and Chi-square test for trend and independence.
results409 patients (median age 75.4, 77% male, 99% White, median follow-up 34.5 months) underwent surgical resection for cHNSCC between 2016 and 2022. While several preoperative PBBMs correlated with tumor size and nodal burden, none were found to predict OS. On univariate analysis, high postoperative relative neutrophils and platelet-to-lymphocyte ratio (PLR) were associated with worse OS. High relative lymphocytes, total albumin, and prognostic nutritional index (PNI) were associated with improved OS. On multivariate analysis, no PBBM was significant for predicting OS.
conclusionThis is the first study to evaluate the prognostic value of PBBMs in cHNSCC. Preoperative PBBMs correlated with tumor size and nodal burden, while high CCI and low postoperative NLRs negatively predicted survival. Further prospective research is needed for validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.